Simona Aschero
Impact in
- Genetics top 5%
- Mesenchymal stem cell research
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 5
- Chromatin Remodeling and Cancer 2
-
- Multiple Myeloma Research and Treatments 5
- Hematopoietic Stem Cell Transplantation 1
- Co-authors
- Massimo Aglietta (1 shared paper)Katia Mareschi (1 shared paper)Enrico Madon (1 shared paper)Ivana Ferrero (1 shared paper)Loretta Gammaitoni (1 shared paper)Franca Fagioli (1 shared paper)Deborah Rustichelli (1 shared paper)Paola Omedè (2 shared papers)
- Journals
- Journal of Cellular Biochemistry (1 paper)Cancer Letters (1 paper)Leukemia (1 paper)Journal of Neuro-Oncology (1 paper)Haematologica (1 paper)
- Partner nations
- ItalyNetherlandsSlovakia
In The Last Decade
Simona Aschero
8 papers receiving 337 citations
Peers
Comparison fields: 5 of 58
- Genetics 210
- Hematology 47
- Cancer Research 47
- Surgery 114
- Urology 14
Countries citing papers authored by Simona Aschero
This map shows the geographic impact of Simona Aschero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Aschero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Aschero more than expected).
Fields of papers citing papers by Simona Aschero
This network shows the impact of papers produced by Simona Aschero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Aschero. The network helps show where Simona Aschero may publish in the future.
Co-authors
The 25 scholars most cited alongside Simona Aschero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 253 | |
| 2 | 2011 | 58 | |
| 3 | 2014 | 17 | |
| 4 | 2015 | 4 | |
| 5 | 2011 | 3 | |
| 6 | Carfilzomib, Cyclophosphamide and dexamethasone (CCD) for newly diagnosed multiple myeloma (MM) patients: initial results of a multicenter, open label phase II study | 2013 | 3 |
| 7 | 2017 | 2 | |
| 8 | 2010 | 1 |
About Simona Aschero
Simona Aschero is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Complementary and alternative medicine, having authored 8 papers that have together received 341 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chromatin Remodeling and Cancer (2 papers), Peptidase Inhibition and Analysis (2 papers), Telomeres, Telomerase, and Senescence (1 paper), Cancer Treatment and Pharmacology (1 paper), Mesenchymal stem cell research (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Genetics (210 citations), Hematology (47 citations), Cancer Research (47 citations), Surgery (114 citations) and Urology (14 citations). Simona Aschero has collaborated with scholars based in Italy, Netherlands and Slovakia. Frequent co-authors include Massimo Aglietta, Katia Mareschi, Enrico Madon, Ivana Ferrero, Loretta Gammaitoni, Franca Fagioli, Deborah Rustichelli, Paola Omedè, Marco Ladetto and Luigia Monitillo. Their work appears in journals such as Journal of Cellular Biochemistry, Cancer Letters, Leukemia, Journal of Neuro-Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.